William Craumer
President bij Lavenir, Inc.
Profiel
William Craumer is currently the President at Lavenir, Inc. He previously worked as the Director-Communications at Illumina, Inc., Investor Relations Contact at Standard BioTools, Inc., and Head-Investor Relations at Applied Biosystems, Inc.
Actieve functies van William Craumer
| Bedrijven | Functie | Begin |
|---|---|---|
| Lavenir, Inc. | President | 01-01-2010 |
Eerdere bekende functies van William Craumer
| Bedrijven | Functie | Einde |
|---|---|---|
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Public Communications Contact | 25-11-2008 |
| STANDARD BIOTOOLS INC. | Public Communications Contact | - |
| ILLUMINA, INC. | Public Communications Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| STANDARD BIOTOOLS INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |
| Lavenir, Inc. |
